Clinical Hospital Dubrava
Zagreb, Croatia
2 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 3
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Leukemia
Daiichi Sankyo700 enrolled288 locationsNCT06578247
Recruiting
Not Applicable
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
Coronary Artery DiseaseHeart Failure, Systolic
Sunnybrook Health Sciences Centre754 enrolled43 locationsNCT05427370
Recruiting
Phase 3
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
Polycythemia Vera
Italfarmaco220 enrolled90 locationsNCT06093672
Recruiting
Phase 3
Study of OCTAPLEX in Patients With Acute Major Bleeding on DOAC Therapy With Factor Xa Inhibitor
Acute Major Bleeding
Octapharma260 enrolled63 locationsNCT04867837
Recruiting
Phase 3
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
MyelofibrosisPrimary MyelofibrosisMF+2 more
Kartos Therapeutics, Inc.600 enrolled215 locationsNCT06479135
Recruiting
Not Applicable
The C-MIC-II Follow-Up Study
Systolic Left Ventricular Dysfunction
Berlin Heals GmbH31 enrolled6 locationsNCT05189860